[go: up one dir, main page]

CN109295123A - A kind of biological production method of beta-flavin - Google Patents

A kind of biological production method of beta-flavin Download PDF

Info

Publication number
CN109295123A
CN109295123A CN201811064631.4A CN201811064631A CN109295123A CN 109295123 A CN109295123 A CN 109295123A CN 201811064631 A CN201811064631 A CN 201811064631A CN 109295123 A CN109295123 A CN 109295123A
Authority
CN
China
Prior art keywords
leu
ala
expression vector
gene
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811064631.4A
Other languages
Chinese (zh)
Inventor
赵广荣
侯亚男
于思礼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN201811064631.4A priority Critical patent/CN109295123A/en
Publication of CN109295123A publication Critical patent/CN109295123A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • C12P17/12Nitrogen as only ring hetero atom containing a six-membered hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了一种甜菜黄素的生物生产方法,包括如下步骤:合成具有两个Ptrc启动子的高拷贝表达载体pHTrc,合成4,5‑多巴雌二醇双加氧酶基因syndoda,从大肠杆菌BL2l(DE3)中克隆得到內源酪氨酸羟化酶基因HpaBC;将基因syndoda和HpaBC与表达载体连接,得到重组表达载体pHTDH,并转化到高产L‑酪氨酸的菌株SyBE‑002444中得到重组大肠杆菌BTX1;将活化的BTX1接种到添加卡那霉素的LB培养基中培养,加入IPTG诱导,饲喂组氨酸、赖氨酸或精氨酸,继续发酵培养,得到甜菜黄素。本发明利用游离诱导表达进行发酵生产不同种类甜菜黄素,解决单一种类的甜菜黄素难以获得的问题。The invention discloses a biological production method of betaflavin, comprising the following steps: synthesizing a high-copy expression vector pHTrc with two P trc promoters, synthesizing a 4,5-dopaestradiol dioxygenase gene syndoda, The endogenous tyrosine hydroxylase gene HpaBC was cloned from Escherichia coli BL21 (DE3); the genes syndoda and HpaBC were connected with the expression vector to obtain the recombinant expression vector pHTDH, and transformed into the high-producing strain SyBE- of L-tyrosine Recombinant Escherichia coli BTX1 was obtained in 002444; the activated BTX1 was inoculated into LB medium supplemented with kanamycin for culture, induced by adding IPTG, fed with histidine, lysine or arginine, and continued to ferment and culture to obtain sugar beet flavin. The invention utilizes free inducible expression to ferment and produce different kinds of betaaxanthin, and solves the problem that a single type of betaaxanthin is difficult to obtain.

Description

A kind of biological production of betaxanthin
Technical field
The invention belongs to biomedicine technical field, it is related to producing the recombinant bacterium of betaxanthin and construction method and purposes.
Background technique
Betaxanthin (betaxanthin) is a kind of yellow form of betanidin (betAin), is typically used as food addition Agent, cosmetic colorant, while having both the bioactivity such as anti-oxidant, antitumor, liver protection and potential health care medical value.
Up to the present the industrial betanidin product overwhelming majority remains in plant extract, edible natural garden beet element Source is even more to be limited in beet and three-coloured amaranth, this also results in the betanidin type scarcity of commercialization and purity is not high.Now can The betanidin product enough obtained is mostly red beet root extract, and different types of betaxanthin there is no realization commodity Change, be merely present in laboratory and prepare on a small scale, this is unfavorable for the big rule for promoting betanidin class natural drug and food additives Mould innovative development and application.
Most countries food additives are all by strictly control, in food and pharmaceutical industry, the benefit of natural pigment With causing more and more to pay close attention to.A kind of natural pigment of the betanidin as safe and non-toxic, be commonly used for food additives come for Food provides color, and as anthocyanidin substitute.Its anti-oxidant, pre- preventing tumor reduces the works such as blood lipid, alleviation muscular fatigue With with important health value.
Summary of the invention
The purpose of the present invention is overcome the deficiencies of the prior art and provide a kind of biological production of betaxanthin.
Technical solution of the present invention is summarized as follows:
A kind of biological production of betaxanthin, includes the following steps:
(1) design and fully synthetic tool is there are two PtrcThe high copy expression carrier pHTrc of promoter, the nucleosides of the pHTrc Acid sequence is as shown in SEQ ID No.3;Artificial fully synthetic 4,5- DOPA estradiol dioxygenase gene syndoda, the gene The nucleotide sequence of syndoda is as shown in SEQ ID No.4;Endogenous tyrosine is obtained from clone in Escherichia coli BL2l (DE3) The nucleotide sequence of '-hydroxylase gene HpaBC, the gene HpaBC are as shown in SEQ ID No.5;
(2) the gene syndoda is connected by digestion connection type and the first set promoter of expression vector pHTrc It connects, obtains recombinant expression carrier pHTD;The gene HpaBC is passed through into digestion connection type and second set of expression vector pHTD Promoter connection, obtains recombinant expression carrier pHTDH;
(3) recombinant expression carrier pHTDH is transformed into the bacterial strain SyBE-002444 of high yield l-tyrosine, to monoclonal Screening obtains the recombination bacillus coli BTX1 for producing betaxanthin;
(4) the recombination bacillus coli BTX1 for producing betaxanthin is activated into 10-12 in the LB culture medium of addition kanamycins Hour;
(5) the recombination bacillus coli BTX1 of activation is cultivated by the LB that 1%-2% volume ratio is inoculated into addition kanamycins In base, culture to OD is 4-6, is transferred in M9 culture medium, continues culture to logarithmic phase;IPTG is added, continues to cultivate, feeding group Propylhomoserin, lysine or arginine continue fermented and cultured, obtain betaxanthin, and the IPTG is isopropyl-β-D-thiogalactose The abbreviation of glycosides.
Step (5) is preferred are as follows: the recombination bacillus coli BTX1 of activation is inoculated into 100mL addition by 1%-2% volume ratio In the LB culture medium of kanamycins, 37 DEG C, 220rpm cultivate to OD be 4-6, be transferred in 50mL M9 culture medium, initial OD is 1.0,30 DEG C, 200rpm continue culture to logarithmic phase;Be added final concentration 0.1mM IPTG, 30 DEG C, 200rpm continue to cultivate, feed Histidine, lysine or the arginine of final concentration 6mM continues fermented and cultured, obtains betaxanthin, and the IPTG is isopropyl- The abbreviation of β-D- thiogalactoside.
Advantages of the present invention:
The recombination bacillus coli of production betaxanthin of the invention, carries out fermenting and producing variety classes using free inducing expression Betaxanthin can solve the problems, such as that the betaxanthin of single kind is difficult to obtain, and provide method to synthesize different betaxanthins.
Detailed description of the invention
Fig. 1 is the synthetic route of betaxanthin.
Fig. 2 is the fully synthetic high copy expression carrier pHTDH schematic diagram of design.
Fig. 3 is the histidine-betaxanthin LC-MS map to be fermented with the recombinant bacterial strain.
Fig. 4 is the HPLC map of the three kinds of betaxanthins in total to be fermented with the recombinant bacterial strain.
Specific embodiment
Utilize artificial fully synthetic 4,5- DOPA estradiol dioxygenase gene syndoda and Escherichia coli endogenous tyrosine Hydroxylase HpaBC gene, realizes de novo formation betalamic acid in engineering colon bacillus.Betalamic acid synthetic quantity most The big stage adds the generation that different amino acid realizes variety classes betaxanthin.
Coli strain E.coli BL21 (DE3) used in the present invention is bought from the complete limited public affairs of formula gold biotechnology in Beijing Department.
Bacillus coli DH 5 alpha competent cell used in the present invention is bought from Beijing Bo Maide gene technology Co., Ltd.
Escherichia coli used in the present invention (escherichia coli) (Escherichia coli) be SyBE_002444, now in China Committee for Culture Collection of Microorganisms's common micro-organisms center's preservation, collection number of registering on the books is CGMCC No.7961.The preservation time is on July 22nd, 2013, and address is the Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Chinese Academy of Sciences Institute of microbiology, postcode 100101.
LB culture medium composition are as follows: 10g/L NaCl, 10g/L tryptone and 5g/L yeast powder, when configuring solid medium 1.5g agar powder is added in every 100mL, sterilize 20min at 121 DEG C of 0.1Mpa pressure.
M9 fermentation medium composition are as follows: 0.5g/L NaCl, 1g/L NH4Cl 3g/L KH2PO4、17.1g/L Na2HPO4· 12H2O, culture medium sterilize 20min at 121 DEG C of 0.1Mpa pressure, and the final concentration 5mM MgSO of sterilizing is then added4、0.1mM CaCl2With 5g/L glucose.
Added kanamycins concentration is 30 μ g/mL in thallus incubation.
IPTG is the abbreviation of isopropyl-β-D-thiogalactoside.
The biosynthesis pathway of betaxanthin of the present invention as shown in Figure 1: glucose through l-tyrosine in endogenous junket L-3,4 dihydroxyphenylalanine is generated under the action of propylhomoserin hydroxylase, L-3,4 dihydroxyphenylalanine generates betaine aldehyde under the catalysis of 4,5- DOPA estradiol dioxygenase Propylhomoserin.The betalamic acid production quantity maximum stage individually adds different types of amino acid or amino acid derivativges, such as when R base point Not Wei 4-methylimidazole, 1- butylamine and when guanidine propyl, addition is respectively histidine, lysine and arginine, continues to close At corresponding betaxanthin.
The present invention is further illustrated combined with specific embodiments below.
Embodiment 1
The acquisition of 4,5- DOPA estradiol dioxygenase gene syndoda and endogenous tyrosine '-hydroxylase gene HpaBC:
The amino acid sequence such as sequence of the 4,5- DOPA estradiol dioxygenase in the source four-o'clock (Mirabilis jApa) In table shown in SEQ ID No.1, in the amino acid sequence of Escherichia coli BL2l (DE3) endogenous tyrosine hydroxylase such as sequence table Shown in SEQ ID No.2.
Using the online codon optimization tool (http://genomes.urv.es/OPTIMIZER/) of OPTIMIZER, with Escherichia coli optimize the Preference of codon, and the full-length gene of design coding MjDODA is named as syndoda, core Nucleotide sequence is as shown in SEQ ID No.4.By the fully synthetic obtained syndoda gene of chemistry, two sides have NcoI and BamHI enzyme Enzyme site.Using e. coli bl21 (DE3) bacterium solution as template, primers F-HPNd, R- containing KpnI and HindIII restriction enzyme site HPKp carries out PCR amplification, obtains overall length HpaBC gene, nucleotide sequence is as shown in SEQ ID No.5.
The primer for cloning HpaBC full-length gene is as follows:
F-HPNd:CGGGGTACCATGAAACCAGAAGATTTCCGC (SEQ ID No.6)
R-HPKp:CCCAAGCTTTTATTAAATCGCAGCTTCCA (SEQ ID No.7)
Embodiment 2
The building of recombinant expression carrier pHTDH:
For having the syndoda genetic fragment of restriction enzyme site, carried out using FastDigest restriction endonuclease NcoI, BamHI Double digestion cuts the pHTrc expression vector (nucleotide sequence of the pHTrc such as SEQ ID No.3 institute with identical restriction endonuclease Show).Reaction system are as follows: 5 μ L 10 × FastDigest Buffer, 2 μ L restriction endonucleases 1,2 μ L restriction endonucleases 2,41 μ L genetic fragments. Reaction condition are as follows: 37 DEG C, 1h.The plasmid vector and target gene fragment obtained after endonuclease reaction, passes through PCR product purification and recovery Operating method in kit carries out purification and recovery.Product after purification is by connection reaction forming at pHTD.Linked system are as follows: 6 μ L digestion genetic fragments, 2 μ L digestion carrier segments, 1 μ L10 × T4 ligase buffer, 1 μ L T4DNA ligase.React item Part are as follows: 22 DEG C, 30min.Reaction system after connection needs conversion in time into competent cell, the specific steps are as follows: super Connection product is added to the DH5 α competent cell of 200 μ L in net workbench, 30min on ice is placed after mixing well.Ice bath The heat shock 90s in 42 DEG C of thermostat water baths of system afterwards is further continued for ice bath 2min, then adds in superclean bench to centrifuge tube Enter 600 μ L LB culture mediums, 37 DEG C, recovery 1h under conditions of 160rpm, after bacterium solution 4500rpm is centrifuged 1min, removal supernatant is trained Base is supported, thallus is resuspended with the LB culture medium of the centrifugation remaining about 50 μ L of bottom of the tube, and be uniformly coated to kalamycin resistance LB solid plate on, plate is placed in 37 DEG C of incubator and cultivates 12h or so and grow single colonie.Drawn with general on carrier Object F-pHTrctest, R-pHTrctest carry out bacterium colony PCR verifying, filter out the correct positive colony of conversion and sequence verification. Make in the same way, double enzymes are carried out to gene HpaBC and plasmid pHTD with FastDigest restriction endonuclease KpnI, HindIII It cuts, is attached after purification, carry out bacterium colony PCR verifying with universal primer F-pHTrctest, R-pHTrctest on carrier, sieve Correct positive colony and sequence verification are selected, plasmid pHTDH is obtained.
Successful pHTDH recombinant expression carrier is constructed for testing in next step.
PTrc universal primer is as follows:
F-pHTrctest:TTTGCGCCGACATCATAACG(SEQ ID No.8)
R-pHTrctest:CAACGTTCAAATCCGCTCCC(SEQ ID No.9)
Embodiment 3
By in the electroporated SyBE-002444 bacterial strain to high yield l-tyrosine of pHTDH recombinant expression carrier, BTX1 is obtained Recombinant bacterial strain.
It operates as follows:
1, the Escherichia coli SyBE-002444 frozen is connected in 5mL LB liquid medium by 1% volume ratio, and 37 DEG C, 220rpm is activated overnight culture.Activated bacterium solution continues to access in 10mL LB liquid medium with 1% volume ratio, 37 DEG C, 220rpm cultivates about 4h.
2, bacterium solution is all poured into the centrifuge tube of pre-cooling, 4000rpm, 4 DEG C of centrifugation 5min, discards the collection of supernatant culture medium Thallus.10% glycerol of 5mL of thallus pre-cooling is resuspended, and continues 4500rpm after mixing, and 4 DEG C of centrifugation 5min are discarded supernatant, This operation is repeated, is cleaned thallus 3 times with glycerol in total.Then 200 μ L, 10% glycerol is added thallus to be resuspended that competence is made is thin Born of the same parents.
3,100 μ L competent cells are drawn, are gone in sterilized and pre-cooling centrifuge tube, and 2.5 μ L structures are added thereto Successful pHTDH expression vector plasmid is built to be uniformly mixed.
4, the mixture of thallus and plasmid is all added in the electric revolving cup of pre-cooling, is put into electroporation, voltage is set 2500V, electroporated 5ms.The cell after electricity turns is sucked out into 1.5mL centrifuge tube, the liquid LB culture of 1mL non-resistant is added Base, piping and druming mixing, 37 DEG C, recovery culture 2h under the conditions of 160rpm.
6, the bacterium solution after drawing recovery in super-clean bench is inhaled 50 μ L and is evenly coated on the LB solid plate of kalamycin resistance, Cultivate 12h in 37 DEG C of constant incubator, the single colonie that picking is grown, until in LB liquid medium, 37 DEG C, 220rpm constant temperature Bacterium is deposited after culture 12h, obtains BTX1 recombinant bacterial strain, cryopreservation.
Embodiment 4
The recombination bacillus coli BTX1 for producing betaxanthin is activated to 10 hours in the LB culture medium of addition kanamycins (in fact It verifies bright, 11 hours or 12 hours can also be activated);
Recombinant bacterium BTX1 fermentation detection:
The recombination bacillus coli BTX1 of activation is inoculated into 100mL by 1% volume ratio (being also possible to by 2% volume ratio) to add Add in the LB culture medium of kanamycins, 37 DEG C, 220rpm cultivate to OD be 5 (being also possible to 4 or 6).It is transferred to 50mL M9 culture In base, 1.0,30 DEG C of initial OD, 200rpm continue culture to logarithmic phase.Final concentration 0.1mM IPTG, 30 DEG C, 200rpm are added Continue to cultivate, feed final concentration 6mM histidine, continues fermented and cultured, obtain betaxanthin.The IPTG is isopropyl-β-D- The abbreviation of thiogalactoside.
High performance liquid chromatography-mass spectrometry (LC-MS) system is carried out after taking 0.22 μm of filtering with microporous membrane of supernatant Detection.Chromatographic condition is as follows: AlltimaTMC18 (5u 250mm × 4.6mm) chromatographic column, 25 DEG C of column temperature;0-25min is linearly terraced Degree, methanol: 1.5% phosphoric acid water=5:95 to methanol: 1.5% phosphoric acid water=60:40,25-30min linear gradient, methanol: 1.5% phosphoric acid water=60:40 is to methanol: 1.5% phosphoric acid water=5:95, flow velocity 1mL/min;UV detector, Detection wavelength 470nm.Mass Spectrometry Conditions are as follows: electron spray positively ionized (ESI+) detection, and scanning range is m/z 50-m/z 1000, spraying electricity Press 4500V, atomization air pressure 0.8Bar, dry 180 DEG C of temperature degree, flow velocity 6L/min;Collision cell radio-frequency voltage: 150.0Vpp.
As shown in figure 3, LC-MS map, which is shown, successfully synthesizes histidine-betaxanthin.
It is demonstrated experimentally that substituting the histidine in the present embodiment with lysine and arginine, it is also possible to obtain corresponding beet Flavine, as shown in figure 3, in addition to generate histidine-betaxanthin, efficient liquid phase chromatic graph also show lysine-betaxanthin and The generation of arginine-betaxanthin.
Illustrative description has been done to the present invention above, it should explanation, in the case where not departing from core of the present invention, Any simple deformation, modification or other skilled in the art can not spend the equivalent replacement of creative work to each fall within Protection scope of the present invention.
Sequence table
<110>University Of Tianjin
<120>a kind of biological production of betaxanthin
<160> 9
<170> SIPOSequenceListing 1.0
<210> 1
<211> 267
<212> PRT
<213>four-o'clock (Mirabilis jalapa)
<400> 1
Met Lys Gly Thr Tyr Tyr Ile Asn His Gly Asp Pro Leu Met Tyr Leu
1 5 10 15
Lys Lys His Ile Lys Leu Arg Gln Phe Leu Glu Gly Trp Gln Glu Asn
20 25 30
Val Val Ile Glu Lys Pro Lys Ser Ile Leu Ile Ile Ser Ala His Trp
35 40 45
Asp Thr Asn Val Pro Thr Val Asn Phe Val Glu His Cys Asp Thr Ile
50 55 60
His Asp Phe Asp Asp Tyr Pro Asp Pro Leu Tyr Gln Ile Gln Tyr Arg
65 70 75 80
Ala Pro Gly Ala Pro Asn Leu Ala Lys Lys Val Glu Glu Leu Leu Lys
85 90 95
Glu Ser Gly Met Glu Cys Glu Ile Asp Thr Lys Arg Gly Leu Asp His
100 105 110
Ala Ala Trp Phe Pro Leu Met Phe Met Tyr Pro Glu Ala Asn Ile Pro
115 120 125
Ile Cys Glu Leu Ser Val Gln Pro Ser Lys Asp Gly Ile His His Tyr
130 135 140
Asn Val Gly Lys Ala Leu Ser Pro Leu Leu Gln Gln Gly Val Leu Ile
145 150 155 160
Ile Gly Ser Gly Gly Thr Val His Pro Ser Asp Asp Thr Pro His Cys
165 170 175
Pro Asn Gly Val Ala Pro Trp Ala Ile Glu Phe Asp Asn Trp Leu Glu
180 185 190
Asp Ala Leu Leu Ser Gly Arg Tyr Glu Asp Val Asn Asn Phe Lys Lys
195 200 205
Leu Ala Pro Asn Trp Glu Ile Ser His Pro Gly Gln Glu His Leu Tyr
210 215 220
Pro Leu His Val Ala Leu Gly Ala Ala Gly Lys Asn Pro Lys Thr Gln
225 230 235 240
Leu Ile His Arg Ser Trp Ala Ala Asn Gly Val Phe Gly Tyr Ser Thr
245 250 255
Tyr Asn Phe Thr Pro Thr Thr Gln Lys Thr Asp
260 265
<210> 2
<211> 690
<212> PRT
<213>Escherichia coli (Escherichia coli)
<400> 2
Met Lys Pro Glu Asp Phe Arg Ala Ser Thr Gln Arg Pro Phe Thr Gly
1 5 10 15
Glu Glu Tyr Leu Lys Ser Leu Gln Asp Gly Arg Glu Ile Tyr Ile Tyr
20 25 30
Gly Glu Arg Val Lys Asp Val Thr Thr His Pro Ala Phe Arg Asn Ala
35 40 45
Ala Ala Ser Val Ala Gln Leu Tyr Asp Ala Leu His Lys Pro Glu Met
50 55 60
Gln Asp Ser Leu Cys Trp Asn Thr Asp Thr Gly Ser Gly Gly Tyr Thr
65 70 75 80
His Lys Phe Phe Arg Val Ala Lys Ser Ala Asp Asp Leu Arg Gln Gln
85 90 95
Arg Asp Ala Ile Ala Glu Trp Ser Arg Leu Ser Tyr Gly Trp Met Gly
100 105 110
Arg Thr Pro Asp Tyr Lys Ala Ala Phe Gly Cys Ala Leu Gly Ala Asn
115 120 125
Pro Gly Phe Tyr Gly Gln Phe Glu Gln Asn Ala Arg Asn Trp Tyr Thr
130 135 140
Arg Ile Gln Glu Thr Gly Leu Tyr Phe Asn His Ala Ile Val Asn Pro
145 150 155 160
Pro Ile Asp Arg His Leu Pro Thr Asp Lys Val Lys Asp Val Tyr Ile
165 170 175
Lys Leu Glu Lys Glu Thr Asp Ala Gly Ile Ile Val Ser Gly Ala Lys
180 185 190
Val Val Ala Thr Asn Ser Ala Leu Thr His Tyr Asn Met Ile Gly Phe
195 200 205
Gly Ser Ala Gln Val Met Gly Glu Asn Pro Asp Phe Ala Leu Met Phe
210 215 220
Val Ala Pro Met Asp Ala Asp Gly Val Lys Leu Ile Ser Arg Ala Ser
225 230 235 240
Tyr Glu Met Val Ala Gly Ala Thr Gly Ser Pro Tyr Asp Tyr Pro Leu
245 250 255
Ser Ser Arg Phe Asp Glu Asn Asp Ala Ile Leu Val Met Asp Asn Val
260 265 270
Leu Ile Pro Trp Glu Asn Val Leu Ile Tyr Arg Asp Phe Asp Arg Cys
275 280 285
Arg Arg Trp Thr Met Glu Gly Gly Phe Ala Arg Met Tyr Pro Leu Gln
290 295 300
Ala Cys Val Arg Leu Ala Val Lys Leu Asp Phe Ile Thr Ala Leu Leu
305 310 315 320
Lys Lys Ser Leu Glu Cys Thr Gly Thr Leu Glu Phe Arg Gly Val Gln
325 330 335
Ala Asp Leu Gly Glu Val Val Ala Trp Arg Asn Thr Phe Trp Ala Leu
340 345 350
Ser Asp Ser Met Cys Ser Glu Ala Thr Pro Trp Val Asn Gly Ala Tyr
355 360 365
Leu Pro Asp His Ala Ala Leu Gln Thr Tyr Arg Val Leu Ala Pro Met
370 375 380
Ala Tyr Ala Lys Ile Lys Asn Ile Ile Glu Arg Asn Val Thr Ser Gly
385 390 395 400
Leu Ile Tyr Leu Pro Ser Ser Ala Arg Asp Leu Asn Asn Pro Gln Ile
405 410 415
Asp Gln Tyr Leu Ala Lys Tyr Val Arg Gly Ser Asn Gly Met Asp His
420 425 430
Val Gln Arg Ile Lys Ile Leu Lys Leu Met Trp Asp Ala Ile Gly Ser
435 440 445
Glu Phe Gly Gly Arg His Glu Leu Tyr Glu Ile Asn Tyr Ser Gly Ser
450 455 460
Gln Asp Glu Ile Arg Leu Gln Cys Leu Arg Gln Ala Gln Asn Ser Gly
465 470 475 480
Asn Met Asp Lys Met Met Ala Met Val Asp Arg Cys Leu Ser Glu Tyr
485 490 495
Asp Gln Asp Gly Trp Thr Val Pro His Leu His Asn Asn Asp Asp Ile
500 505 510
Asn Met Leu Asp Lys Leu Leu Lys Met Gln Leu Asp Glu Gln Arg Leu
515 520 525
Arg Phe Arg Asp Ala Met Ala Ser Leu Ser Ala Ala Val Asn Ile Ile
530 535 540
Thr Thr Glu Gly Asp Ala Gly Gln Cys Gly Ile Thr Ala Thr Ala Val
545 550 555 560
Cys Ser Val Thr Asp Thr Pro Pro Ser Leu Met Val Cys Ile Asn Ala
565 570 575
Asn Ser Ala Met Asn Pro Val Phe Gln Gly Asn Gly Lys Leu Cys Val
580 585 590
Asn Val Leu Asn His Glu Gln Glu Leu Met Ala Arg His Phe Ala Gly
595 600 605
Met Thr Gly Met Ala Met Glu Glu Arg Phe Ser Leu Ser Cys Trp Gln
610 615 620
Lys Gly Pro Leu Ala Gln Pro Val Leu Lys Gly Ser Leu Ala Ser Leu
625 630 635 640
Glu Gly Glu Ile Arg Asp Val Gln Ala Ile Gly Thr His Leu Val Tyr
645 650 655
Leu Val Glu Ile Lys Asn Ile Ile Leu Ser Ala Glu Gly His Gly Leu
660 665 670
Ile Tyr Phe Lys Arg Arg Phe His Pro Val Met Leu Glu Met Glu Ala
675 680 685
Ala Ile
690
<210> 3
<211> 2775
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 3
gtttgacagc ttatcatcga ctgcacggtg caccaatgct tctggcgtca ggcagccatc 60
ggaagctgtg gtatggctgt gcaggtcgta aatcactgca taattcgtgt cgctcaaggc 120
gcactcccgt tctggataat gttttttgcg ccgacatcat aacggttctg gcaaatattc 180
tgaaatgagc tgttgacaat taatcatccg gctcgtataa tgtttcacac aggaaacacc 240
atggcatgga tccttgacaa ttaatcatcc ggctcgtata atgtttcaca caggaaacag 300
gtaccatatg ggaattcgtc gaagcttggg ccccaaataa aacgaaaggc tcagtcgaaa 360
gactgggcct ttcgttttat ctgttgtttg tcggtgaacg ctctcctgag taggacaaat 420
ccgccgggag cggatttgaa cgttgcgaag caacggcccg gagggtggcg ggcaggacgc 480
ccgccataaa ctgccaggca tcaaattaag cagaaggcca tcctgacgga tggccttttt 540
gcgtttctac aaactctttt agaaaaactc atcgagcatc aaatgaaact gcaatttatt 600
catatcagga ttatcaatac catatttttg aaaaagccgt ttctgtaatg aaggagaaaa 660
ctcaccgagg cagttccata ggatggcaag atcctggtat cggtctgcga ttccgactcg 720
tccaacatca atacaaccta ttaatttccc ctcgtcaaaa ataaggttat caagtgagaa 780
atcaccatga gtgacgactg aatccggtga gaatggcaaa agtttatgca tttctttcca 840
gacttgttca acaggccagc cattacgctc gtcatcaaaa tcactcgcat caaccaaacc 900
gttattcatt cgtgattgcg cctgagcgag acgaaatacg cggtcgctgt taaaaggaca 960
attacaaaca ggaatcgaat gcaaccggcg caggaacact gccagcgcat caacaatatt 1020
ttcacctgaa tcaggatatt cttctaatac ctggaatgct gttttcccgg ggatcgcagt 1080
ggtgagtaac catgcatcat caggagtacg gataaaatgc ttgatggtcg gaagaggcat 1140
aaattccgtc agccagttta gtctgaccat ctcatctgta acatcattgg caacgctacc 1200
tttgccatgt ttcagaaaca actctggcgc atcgggcttc ccatacaatc gatagattgt 1260
cgcacctgat tgcccgacat tatcgcgagc ccatttatac ccatataaat cagcatccat 1320
gttggaattt aatcgcggcc tagagcaaga cgtttcccgt tgaatatggc tcatactctt 1380
cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg gatacatatt 1440
tgaatgtatt tagaaaaata aacaaactgt cagaccaagt ttactcatat atactttaga 1500
ttgatttaaa acttcatttt taatttaaaa ggatctaggt gaagatcctt tttgataatc 1560
tcatgaccaa aatcccttaa cgtgagtttt cgttccactg agcgtcagac cccgtagaaa 1620
agatcaaagg atcttcttga gatccttttt ttctgcgcgt aatctgctgc ttgcaaacaa 1680
aaaaaccacc gctaccagcg gtggtttgtt tgccggatca agagctacca actctttttc 1740
cgaaggtaac tggcttcagc agagcgcaga taccaaatac tgtccttcta gtgtagccgt 1800
agttaggcca ccacttcaag aactctgtag caccgcctac atacctcgct ctgctaatcc 1860
tgttaccagt ggctgctgcc agtggcgata agtcgtgtct taccgggttg gactcaagac 1920
gatagttacc ggataaggcg cagcggtcgg gctgaacggg gggttcgtgc acacagccca 1980
gcttggagcg aacgacctac accgaactga gatacctaca gcgtgagcta tgagaaagcg 2040
ccacgcttcc cgaagggaga aaggcggaca ggtatccggt aagcggcagg gtcggaacag 2100
gagagcgcac gagggagctt ccagggggaa acgcctggta tctttatagt cctgtcgggt 2160
ttcgccacct ctgacttgag cgtcgatttt tgtgatgctc gtcagggggg cggagcctat 2220
ggaaaaacgc cagcaacgcg gcctttttac ggttcctggc cttttgctgg ccttttgctc 2280
acatgttctt tcctgcgtta tcccctgatt ctgtggataa ccgtattacc gcctttgagt 2340
gagctgatac cgctcgccgc agccgaacga ccgagcgcag cgagtcagtg agcgaggaag 2400
cggaagagcg cctgatgcgg tattttctcc ttacgcatct gtgcggtatt tcacaccgca 2460
tatggtgcac tctcagtaca atctgctctg atgccgcata gttaagccag tatacactcc 2520
gctatcgcta cgtgactggg tcatggctgc gccccgacac ccgccaacac ccgctgacgc 2580
gccctgacgg gcttgtctgc tcccggcatc cgcttacaga caagctgtga ccgtctccgg 2640
gagctgcatg tgtcagaggt tttcaccgtc atcaccgaaa cgcgcgaggc agcagatcaa 2700
ttcgcgcgcg aaggcgaagc ggcatgcatt tacgttgcgc aacgcaatta atgtgagtta 2760
gcgcgaattg atctg 2775
<210> 4
<211> 825
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 4
catgccatgg gcatgaaagg gacatactat attaatcacg gcgaccctct gatgtacctg 60
aaaaagcaca ttaaattgcg tcagttcctg gagggttggc aggagaacgt tgtgatcgaa 120
aagccgaagt ccattctgat catttccgcc cattgggaca ctaacgtgcc gactgtgaac 180
ttcgtggaac attgcgacac catccacgat ttcgacgact acccggaccc actgtatcag 240
atccagtatc gcgcaccggg tgctcctaac ctggctaaaa aagttgagga gctgctgaaa 300
gagtctggta tggagtgcga aattgatacc aaacgtggtc tggatcacgc agcgtggttc 360
ccgctgatgt tcatgtatcc ggaagctaat attcctattt gtgaactctc tgttcagccg 420
agcaaagacg gtattcacca ttacaacgtg ggcaaggcac tgtcaccgct gctccaacag 480
ggtgttctga tcatcggttc gggcggcacc gttcacccga gcgacgacac cccgcactgc 540
ccgaacggtg ttgcgccctg ggctatcgag tttgataact ggctggaaga tgccctgctg 600
tctggtcgtt acgaagatgt taacaacttt aaaaagctgg caccgaactg ggaaatctcc 660
cacccgggcc aggagcacct gtatccgctg cacgttgcac tgggcgcggc tggtaaaaac 720
ccgaaaaccc aactgattca tcgttcctgg gcggccaacg gcgtattcgg ttatagcact 780
tacaacttca cccctactac tcaaaaaacg gactaaggat ccgcg 825
<210> 5
<211> 2114
<212> DNA
<213>Escherichia coli (Escherichia coli)
<400> 5
cggggtacca tgaaaccaga agatttccgc gccagtaccc aacgtccttt caccggggaa 60
gagtatctga aaagcctgca ggatggtcgc gagatctata tctatggcga gcgagtgaaa 120
gacgtcacca ctcatccggc atttcgtaat gcggcagcgt ctgttgccca gctgtacgac 180
gcactgcaca aaccggagat gcaggactct ctgtgttgga acaccgacac cggcagcggc 240
ggctataccc ataaattctt ccgcgtggcg aaaagtgccg acgacctgcg ccagcaacgc 300
gacgccatcg ctgagtggtc acgcctgagc tatggctgga tgggccgtac cccagactac 360
aaagccgctt tcggttgcgc actgggcgcg aatccgggct tttacggtca gttcgagcag 420
aacgcccgta actggtacac ccgtattcag gaaactggcc tctactttaa ccacgcgatt 480
gttaacccac cgatcgatcg tcatttgccg accgataaag tgaaagacgt ttacatcaag 540
ctggaaaaag agactgacgc cgggattatc gtcagcggtg cgaaagtggt tgccaccaac 600
tcggcgctga ctcactacaa catgattggc ttcggctcgg cacaagtgat gggcgaaaac 660
ccggacttcg cactgatgtt cgttgcgcca atggatgccg atggcgtgaa attaatctcc 720
cgcgcctctt atgagatggt cgcgggtgct accggctcgc catacgacta cccgctctcc 780
agccgcttcg atgagaacga tgcgattctg gtgatggata acgtgctgat tccatgggaa 840
aacgtgctga tctaccgcga ttttgatcgc tgccgtcgct ggacgatgga aggcggtttt 900
gcccgtatgt atccgctgca agcctgtgtg cgcctggcag tgaaattaga cttcattacg 960
gcactgctga aaaaatcact cgaatgtacc ggcaccctgg agttccgtgg tgtgcaggcc 1020
gatctcggtg aagtggtagc gtggcgcaac accttctggg cattgagtga ctcgatgtgt 1080
tcagaagcaa cgccgtgggt caacggggct tatttaccgg atcatgccgc actgcaaacc 1140
tatcgcgtac tggcaccaat ggcctacgcg aagatcaaaa acattatcga acgcaacgtt 1200
accagtggcc tgatctatct cccttccagt gcccgtgacc tgaataatcc gcagatcgac 1260
cagtatctgg cgaagtatgt gcgcggttcg aacggtatgg atcacgtcca gcgcatcaag 1320
atcctcaaac tgatgtggga tgctattggc agcgaatttg gtggtcgtca cgaactgtat 1380
gaaatcaact actccggtag ccaggatgag attcgcctgc agtgtctgcg ccaggcacaa 1440
aactccggca atatggacaa gatgatggcg atggttgatc gctgcctgtc ggaatacgac 1500
caggacggct ggactgtgcc gcacctgcac aacaacgacg atatcaacat gctggataag 1560
ctgctgaaat aacgcagcag gaggttaaga tgcaattaga tgaacaacgc ctgcgctttc 1620
gtgacgcgat ggccagcctg tcggcagcgg taaatattat caccaccgag ggcgacgccg 1680
gacaatgcgg gattacggca acggccgtct gctcggtcac ggatacacca ccgtcgctga 1740
tggtgtgcat taacgccaac agtgcgatga acccggtttt tcagggcaac ggcaagttgt 1800
gcgtcaacgt cctcaaccat gagcaggaac tgatggcacg ccacttcgcg ggcatgacag 1860
gcatggcgat ggaagagcgt tttagcctct catgctggca aaaaggtccg ctggcgcagc 1920
cggtgctaaa aggttcgctg gccagtcttg aaggtgagat ccgcgatgtg caggcaattg 1980
gcacacatct ggtgtatctg gtggagatta aaaacatcat cctcagtgca gaaggtcatg 2040
gacttatcta ctttaaacgc cgtttccatc cggtgatgct ggaaatggaa gctgcgattt 2100
aataaaagct tggg 2114
<210> 6
<211> 30
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 6
cggggtacca tgaaaccaga agatttccgc 30
<210> 7
<211> 29
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 7
cccaagcttt tattaaatcg cagcttcca 29
<210> 8
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 8
tttgcgccga catcataacg 20
<210> 9
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 9
caacgttcaa atccgctccc 20

Claims (2)

1.一种甜菜黄素的生物生产方法,其特征是包括如下步骤:1. a biological production method of beta-flavin, is characterized in that comprising the steps: (1)设计并全合成具有两个Ptrc启动子的高拷贝表达载体pHTrc,所述pHTrc的核苷酸序列如SEQ ID No.3所示;人工全合成4,5-多巴雌二醇双加氧酶基因syndoda,所述基因syndoda的核苷酸序列如SEQ ID No.4所示;从大肠杆菌BL2l(DE3)中克隆得到內源酪氨酸羟化酶基因HpaBC,所述基因HpaBC的核苷酸序列如SEQ ID No.5所示;(1) Design and fully synthesize a high-copy expression vector pHTrc with two P trc promoters, the nucleotide sequence of pHTrc is shown in SEQ ID No. 3; artificial total synthesis of 4,5-dopaestradiol The dioxygenase gene syndoda, the nucleotide sequence of the gene syndoda is shown in SEQ ID No. 4; the endogenous tyrosine hydroxylase gene HpaBC was cloned from Escherichia coli BL21 (DE3), and the gene HpaBC The nucleotide sequence is shown in SEQ ID No.5; (2)将所述基因syndoda通过酶切连接方式与表达载体pHTrc的第一套启动子连接,得到重组表达载体pHTD;将所述基因HpaBC通过酶切连接方式与表达载体pHTD的第二套启动子连接,得到重组表达载体pHTDH;(2) connecting the gene syndoda with the first set of promoters of the expression vector pHTrc by enzymatic cleavage to obtain a recombinant expression vector pHTD; connecting the gene HpaBC with the second set of the expression vector pHTD through enzymatic cleavage sub-connected to obtain the recombinant expression vector pHTDH; (3)将重组表达载体pHTDH转化到高产L-酪氨酸的菌株SyBE-002444中,对单克隆筛选,获得产甜菜黄素的重组大肠杆菌BTX1;(3) The recombinant expression vector pHTDH was transformed into the high L-tyrosine-producing strain SyBE-002444, and the single clone was screened to obtain a beta-flavin-producing recombinant Escherichia coli BTX1; (4)将产甜菜黄素的重组大肠杆菌BTX1在添加卡那霉素的LB培养基中活化10-12小时;(4) activating beta-flavin-producing recombinant Escherichia coli BTX1 in LB medium supplemented with kanamycin for 10-12 hours; (5)将活化的重组大肠杆菌BTX1按1%-2%体积比接种到添加卡那霉素的LB培养基中,培养至OD为4-6,转接到M9培养基中,继续培养至对数期;加入IPTG,继续培养,饲喂组氨酸、赖氨酸或精氨酸,继续发酵培养,得到甜菜黄素,所述IPTG为异丙基-β-D-硫代半乳糖苷的缩写。(5) Inoculate the activated recombinant Escherichia coli BTX1 into the LB medium supplemented with kanamycin at a volume ratio of 1%-2%, cultivate to an OD of 4-6, transfer it to the M9 medium, and continue to cultivate until Logarithmic phase; add IPTG, continue to culture, feed histidine, lysine or arginine, continue to ferment and culture to obtain betaflavin, the IPTG is isopropyl-β-D-thiogalactoside abbreviation of. 2.根据权利要求1所述的方法,其特征是所述步骤(5)为:将活化的重组大肠杆菌BTX1按1%-2%体积比接种到100mL添加卡那霉素的LB培养基中,37℃、220rpm培养至OD为4-6,转接到50mL M9培养基中,初始OD为1.0,30℃、200rpm继续培养至对数期;加入终浓度0.1mMIPTG,30℃、200rpm继续培养,饲喂终浓度6mM的组氨酸、赖氨酸或精氨酸,继续发酵培养,得到甜菜黄素,所述IPTG为异丙基-β-D-硫代半乳糖苷的缩写。2. method according to claim 1, is characterized in that described step (5) is: by 1%-2% volume ratio inoculate in the LB substratum of 100mL adding kanamycin by the activated recombinant Escherichia coli BTX1 , cultivated at 37°C, 220rpm until the OD is 4-6, transferred to 50mL M9 medium, the initial OD was 1.0, continued to cultivate to log phase at 30°C, 200rpm; added final concentration of 0.1mM IPTG, continued to culture at 30°C, 200rpm , feeding histidine, lysine or arginine with a final concentration of 6 mM, and continuing to ferment and culture to obtain betaflavin, the IPTG is the abbreviation of isopropyl-β-D-thiogalactoside.
CN201811064631.4A 2018-09-12 2018-09-12 A kind of biological production method of beta-flavin Pending CN109295123A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811064631.4A CN109295123A (en) 2018-09-12 2018-09-12 A kind of biological production method of beta-flavin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811064631.4A CN109295123A (en) 2018-09-12 2018-09-12 A kind of biological production method of beta-flavin

Publications (1)

Publication Number Publication Date
CN109295123A true CN109295123A (en) 2019-02-01

Family

ID=65166785

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811064631.4A Pending CN109295123A (en) 2018-09-12 2018-09-12 A kind of biological production method of beta-flavin

Country Status (1)

Country Link
CN (1) CN109295123A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112813013A (en) * 2021-02-06 2021-05-18 江南大学 Recombinant escherichia coli for producing hydroxytyrosol and application thereof
CN116144614A (en) * 2022-10-21 2023-05-23 浙大宁波理工学院 4-hydroxyphenylacetic acid-3-hydroxylase mutant and application thereof
CN117586975A (en) * 2024-01-17 2024-02-23 中国人民解放军军事科学院军事医学研究院 Application of dopa dioxygenase HhDODA1 and its encoding gene in betalain synthesis

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060212968A1 (en) * 2005-02-28 2006-09-21 Goldman Irwin L High pigment golden beets
WO2013058642A1 (en) * 2011-10-17 2013-04-25 Lugo Radillo Agustin Use of betaxanthins and derivatives thereof for the preparation of a drug for the treatment of prediabetes and diabetes
CN104672082A (en) * 2015-02-10 2015-06-03 天津大学 Method for enriching tanshinol in fermentation broth by using macroporous resin
WO2017122189A1 (en) * 2015-09-10 2017-07-20 Yeda Research And Development Co. Ltd. COMPOSITIONS COMPRISING CYP76AD1-β CLADE POLYPEPTIDES AND USES THEREOF
CN107460152A (en) * 2016-06-03 2017-12-12 天津大学 Produce recombinant bacterium, construction method and the purposes of rhodioside and the like

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060212968A1 (en) * 2005-02-28 2006-09-21 Goldman Irwin L High pigment golden beets
WO2013058642A1 (en) * 2011-10-17 2013-04-25 Lugo Radillo Agustin Use of betaxanthins and derivatives thereof for the preparation of a drug for the treatment of prediabetes and diabetes
CN104672082A (en) * 2015-02-10 2015-06-03 天津大学 Method for enriching tanshinol in fermentation broth by using macroporous resin
WO2017122189A1 (en) * 2015-09-10 2017-07-20 Yeda Research And Development Co. Ltd. COMPOSITIONS COMPRISING CYP76AD1-β CLADE POLYPEPTIDES AND USES THEREOF
CN107460152A (en) * 2016-06-03 2017-12-12 天津大学 Produce recombinant bacterium, construction method and the purposes of rhodioside and the like

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GENBANK DATABASE: "Accession ID:B6FOW8.1,RecName: Full=4,5-DOPA dioxygenase extradiol; Short=MjDOD; AltName: Full=DOPA 4,5-dioxygenase", 《GENBANK DATABASE》 *
GENBANK DATABASE: "Accession ID:WP_000801472.1,MULTISPECIES: 4-hydroxyphenylacetate 3-monooxygenase, oxygenase component [Enterobacteriaceae]", 《GENBANK DATABASE》 *
GENBANK DATABASE: "Accession ID:WP_001175460.1,MULTISPECIES: 4-hydroxyphenylacetate 3-monooxygenase [Enterobacteriaceae]", 《GENBANK DATABASE》 *
RETURN TO ISSUEPREVARTICLENEXT: "n Vitro Synthesis of Betaxanthins Using Recombinant DOPA 4,5-Dioxygenase and Evaluation of Their Radical-Scavenging Activities", 《JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY》 *
于思礼: "甜菜素的生物合成及其代谢调控进展", 《中国生物工程杂志》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112813013A (en) * 2021-02-06 2021-05-18 江南大学 Recombinant escherichia coli for producing hydroxytyrosol and application thereof
CN112813013B (en) * 2021-02-06 2023-04-28 江南大学 Recombinant escherichia coli for producing hydroxytyrosol and application thereof
CN116144614A (en) * 2022-10-21 2023-05-23 浙大宁波理工学院 4-hydroxyphenylacetic acid-3-hydroxylase mutant and application thereof
CN117586975A (en) * 2024-01-17 2024-02-23 中国人民解放军军事科学院军事医学研究院 Application of dopa dioxygenase HhDODA1 and its encoding gene in betalain synthesis
CN117586975B (en) * 2024-01-17 2024-04-19 中国人民解放军军事科学院军事医学研究院 Application of DOPA dioxygenase HhDODA1 and its encoding gene in betalain biosynthesis

Similar Documents

Publication Publication Date Title
KR101106253B1 (en) Escherichia coli comprising a polynucleotide encoding a Pycos 3-epimerase enzyme and a method for producing Pycos using the same
CN111235080B (en) Gene recombination escherichia coli and production method of 5-hydroxytryptamine
CN111154707B (en) Method for producing genetically engineered escherichia coli and melatonin
CN109295123A (en) A kind of biological production method of beta-flavin
CN108148797B (en) Method for producing N-acetylglucosamine by co-utilizing glucose and xylose based on CRISPR
KR102700388B1 (en) Method for continuous production of recombinant GLP-1 peptide by bacteria
CN106834331B (en) rBCG for expressing fusion gene of Brucella melitensis P39 and L7/L12 and construction method thereof
CN111394383B (en) Synechococcus genetically engineered bacteria for biosynthesizing caryophyllene and its construction method and application
CN114107368B (en) Combined expression vector for expressing trans-chrysanthemic acid and application thereof in regulation and control of synthesis of trans-chrysanthemic acid by tomato VI glandular wool
CN113755412B (en) Genetically engineered bacterium for producing MK-7, method and application
CN111088267B (en) A kind of method for increasing the density of solvent-producing Clostridium liquid fermentation cells
CN112592877B (en) Recombinant escherichia coli for over-expressing lsrC gene and construction method and application thereof
CN106479928B (en) A strain of high-salt-resistant and high-COD-resistant Salinococcus strain and the endogenous plasmid derived from the strain
CN111909914B (en) Highly PAM Compatible Truncated Variant txCas9 of Endonuclease SpCas9 and Its Applications
CN115141856B (en) Recombinant clostridium and construction method and application thereof
CN114774472B (en) Construction and application of recombinant escherichia coli resistant to pentanediamine
CN110272881B (en) Endonuclease SpCas9 Highly Specific Truncating Variant TSpCas9-V1/V2 and Its Application
CN114369593B (en) Method for preparing chiral amine by silica-binding peptide-mediated alcohol dehydrogenase and amine dehydrogenase co-immobilization cascade reaction
CN106636023B (en) A method of enhancing zwf gene promoter expression intensity
CN112899211A (en) Method for increasing yield of 2-KLG in gluconobacter oxydans
KR101226644B1 (en) Transformed Escherichia coli for Over-expression of Fatty Acid Biosynthesis Pathway and Method of Preparing the Same
CN114736310B (en) Protein and biological material for producing circovirus type 2 virus-like particles and application
CN106854654B (en) rBCG expressing L7/L12 gene of Brucella herba and its construction method and application
CN111254104B (en) Preparation method of genetically engineered escherichia coli and indole-3-acetic acid
CN106676124B (en) rBCG for expressing ovine brucella P39 gene and construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190201

WD01 Invention patent application deemed withdrawn after publication